Enterprise dynamics
Corporate News
-
03-232026Enrollment completed! The Phase III clin...Recently, the multicenter, randomized, double-blind, positive drug-controlled Phase III clinical stu...
-
03-052026Xuanzhu (Beijing) has been included in tRecently, the National Intellectual Property Administration released the list of demonstration entit...
-
01-012026A welcome breakthrough for patients with...Today, pirrolimus has been officially included in the National Medical Insurance Drug List! On D...
-
08-132021The CDK 4 / 6 inhibitor Birociclib, a inRecently, XZenith received the notice that CDE has approved the phase III clinical trial of class 1 ...
-
06-242021XZenith successfully passed the Drug ManOn June 23, XZenith welcomed a group of three experts from Beijing Municipal Medical Products Admini...
9th Floor, North Tower of CP Center, No.20 Jin He East Avenue,Chaoyang District,Beijing,China
Tel：010-5765 4567
Email：XZGROUP@xuanzhubio.com
Copyright © 轩竹生物科技有限公司保留所有权利 冀ICP备2020028968号-2 网站建设技术支持：唯引互动
